Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Sarcoma 1Genitourinary 1

Conditions

Neoplasm Metastasis 4Breast Neoplasms 3Multiple Myeloma 2Sarcoma, Ewing 1Osteoporotic Fractures 1Osteoporosis 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasms 1Musculoskeletal Pain 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Arthralgia 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Diphosphonates × Clear all
NCT07043608 2026-05-01

ZAMBONI

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT00987636 2019-10-22

EWING2008

University Hospital Muenster

Phase 3 Completed
907 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma, Ewing

NCT01129336 2014-05-20

MACS1295

Novartis

Phase 4 Completed
44 enrolled 10 charts
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis

NCT00091832 2014-01-28

Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer

Amgen

Phase 2 Completed
255 enrolled 34 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡